Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2018
Correlation of dose with toxicity and tumour response to <sup>90</sup>Y- and <sup>177</sup>Lu-PRRT provides the basis for optimization through individualized treatment planningMarta Cremonesi, Mahila Esmeralda Ferrari, Lisa Bodei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2007
Sentinel node in breast cancer procedural guidelinesJohn Buscombe, Giovanni Paganelli, Zeynep E Burak, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 25, 2016
The Italian multicentre dosimetric study for lesion dosimetry in <sup>223</sup>Ra therapy of bone metastases: Calibration protocol of gamma cameras and patient eligibility criteriaMassimiliano Pacilio, Bartolomeo Cassano, Carlo Chiesa, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 15, 2024
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat StudyMarianna Maspero, Carlo Sposito, Marco A Bongini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2019
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working groupRiad Salem, Siddharth A Padia, Marnix Lam, et al.
EJNMMI Physics|December 5, 2017
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European surveyKatarina Sjögreen Gleisner, Emiliano Spezi, Pavel Solny, et al.
Hepatology (Baltimore, Md.)|August 23, 2012
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyVincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, et al.
Frontiers in Oncology|September 6, 2014
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveMarta Cremonesi, Carlo Chiesa, Lidia Strigari, et al.
Cardiovascular and Interventional Radiology|June 15, 2014
Intrahepatic flow redistribution in patients treated with radioembolizationCarlo Spreafico, Carlo Morosi, Marco Maccauro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2024
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [<sup>177</sup>Lu]Lu-DOTATATEMarco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, et al.
Pageof 5